An observational, population-based cohort design study to evaluate utilisation of a new once weekly injection for type 2 diabetes mellitus.
Phase of Trial: Phase IV
Latest Information Update: 06 Oct 2015
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 06 Oct 2015 New trial record
- 26 Aug 2015 Results presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.